Literature DB >> 33936909

From Kidney to Brain: An Uncommon Severe Relapse of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody (MPO-ANCA) Vasculitis.

Tiago Araújo1,2, Rúben Maia3, João Massano2,4, Luis Mendonça5, Joana Guimarães2,4.   

Abstract

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of rare autoimmune diseases that affect medium and small blood vessels, with uncommon, variable central nervous system (CNS) involvement. It poses diagnosis challenges due to the limited accuracy of conventional imaging and vast differential diagnosis. We describe the case of a 76-year-old man with a previously diagnosed myeloperoxidase (MPO)-positive AAV with exclusive renal involvement. The patient presented to our emergency department (ED) with sudden-onset weakness of the right side of the body, difficulty speaking, fever, and a history of progressive cognitive impairment in the previous three months (loss of memory, time and space disorientation, acalculia). Brain imaging showed multiple acute and subacute ischemic lesions, suggesting CNS vasculitic involvement. The patient was treated with methylprednisolone pulses, followed by rituximab, with motor and cognitive improvement. Timely diagnosis and adequate treatment of AAV as a cause for new-onset neurological symptoms are crucial to improve outcomes. Otherwise, a higher risk of relapse remains, and extensive neurological deficits may become permanent. Evidence regarding the best treatment options in these patients is scarce and case reports provide further data on this topic.
Copyright © 2021, Araújo et al.

Entities:  

Keywords:  anca-associated vasculitis; central nervous system; ischemic lesions; mpo-anca; rituximab

Year:  2021        PMID: 33936909      PMCID: PMC8086049          DOI: 10.7759/cureus.14205

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  16 in total

1.  Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

Authors:  Gunnar Tomasson; Peter C Grayson; Alfred D Mahr; Michael Lavalley; Peter A Merkel
Journal:  Rheumatology (Oxford)       Date:  2011-10-29       Impact factor: 7.580

Review 2.  ANCA-Associated Vasculitis: Core Curriculum 2020.

Authors:  Duvuru Geetha; J Ashley Jefferson
Journal:  Am J Kidney Dis       Date:  2019-07-26       Impact factor: 8.860

3.  Renal-limited vasculitis with elevated levels of multiple antibodies.

Authors:  Noriaki Sato; Hideki Yokoi; Hirotaka Imamaki; Eiichiro Uchino; Kaoru Sakai; Takeshi Matsubara; Tatsuo Tsukamoto; Sachiko Minamiguchi; Motoko Yanagita
Journal:  CEN Case Rep       Date:  2017-03-03

4.  Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Authors:  Sophia Lionaki; Elizabeth R Blyth; Susan L Hogan; Yichun Hu; Brent A Senior; Caroline E Jennette; Patrick H Nachman; J Charles Jennette; Ronald J Falk
Journal:  Arthritis Rheum       Date:  2012-10

5.  Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines-Executive summary.

Authors:  Joanna Tieu; Rona Smith; Neil Basu; Paul Brogan; David D'Cruz; Neeraj Dhaun; Oliver Flossmann; Lorraine Harper; Rachel B Jones; Peter C Lanyon; Raashid A Luqmani; Stephen P McAdoo; Chetan Mukhtyar; Fiona A Pearce; Charles D Pusey; Joanna C Robson; Alan D Salama; Lucy Smyth; Richard A Watts; Lisa C Willcocks; David R W Jayne
Journal:  Rheumatology (Oxford)       Date:  2020-04-01       Impact factor: 7.580

6.  Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes.

Authors:  Gonzalo De Luna; Benjamin Terrier; Pierre Kaminsky; Alain Le Quellec; François Maurier; Roser Solans; Pascal Godmer; Nathalie Costedoat-Chalumeau; Raphaèle Seror; Pierre Charles; Pascal Cohen; Xavier Puéchal; Luc Mouthon; Loic Guillevin
Journal:  Rheumatology (Oxford)       Date:  2014-09-03       Impact factor: 7.580

Review 7.  Central Nervous System Disease in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.

Authors:  Jonathan Graf
Journal:  Rheum Dis Clin North Am       Date:  2017-11       Impact factor: 2.670

Review 8.  ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.

Authors:  Divi Cornec; Emilie Cornec-Le Gall; Fernando C Fervenza; Ulrich Specks
Journal:  Nat Rev Rheumatol       Date:  2016-07-28       Impact factor: 20.543

9.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

Review 10.  Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know.

Authors:  Yang Zheng; Yinxi Zhang; Mengting Cai; Nanxi Lai; Zhong Chen; Meiping Ding
Journal:  Front Neurol       Date:  2019-01-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.